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Abstract
Greater understanding of the pathophysiology of carbon dioxide kinetics during steady and
nonsteady state should improve, we believe, clinical care during intensive care treatment.
Capnography and the measurement of end-tidal partial pressure of carbon dioxide (PETCO2)
will gradually be augmented by relatively new measurement methodology, including the
volume of carbon dioxide exhaled per breath (VCO2,br) and average alveolar expired PCO2
(PAE –CO2). Future directions include the study of oxygen kinetics.
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CPR = cardiopulmonary resuscitation; ETT = endotracheal tube; FCO2 = fractional carbon dioxide; FRC = functional residual capacity; PCO2 =
partial carbon dioxide tension; PEEP = positive end-expiratory pressure; Q
• = blood flow; RPA = right pulmonary artery; V = volume; V
• = ventilation.
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Introduction
Carbon dioxide is produced in the tissues by aerobic
plus/minus anaerobic metabolism (Fig. 1a), transported in
blood to the lung by venous return (essentially equal to
cardiac output [Q
•
T]), and eliminated from the lung by
minute ventilation (V
•
E) [1]. In this model the lung is a
simple mixing chamber and the alveolar fractional carbon
dioxide (FACO2) is given by
FACO2 = V
•
CO2,ti/V
•
A + FICO2 (1)
where V
•
CO2,ti is the tissue carbon dioxide production, V
•
A is
alveolar ventilation, and FICO2 is the inspired FCO2. If one
assumes no diffusion defect for carbon dioxide, then the
partial carbon dioxide tension (PCO2) of arterial blood
(PaCO2) leaving the lung is the perfusion-weighted
average alveolar PCO2 (PACO2). Note that pulmonary shunt
will add mixed venous blood with high PCO2 (Pv –CO2) to
arterial blood and slightly increase PaCO2 [2]. V
•
A is the
product of respiratory frequency and expired tidal volume
(VT). Expired VT is composed of alveolar VT and total phys-
iologic dead space (VDphy). The fraction VDphy/VT is given
by
VDphy/VT = (PaCO2 – PE
–CO2)/PaCO2 (2)
where PE
–CO2 is the mixed expired PCO2 [2]. In turn, VDphy
is partitioned into anatomic dead space (VDana; conducting
airways that do not participate in gas exchange) and alve-
olar dead space (VDalv; ventilated alveolar units that are
devoid of perfusion; Fig. 2). VDalv/VTalv is given by
VDalv/VTalv = (PaCO2 – PACO2)/PaCO2 (3)
where PACO2 is the alveolar PCO2, estimated either from
PETCO2 or PAE — CO2 [2] (see below). The PaCO2–PETCO
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gradient results from the presence of VDalv or high alveolar
ventilation-to-blood flow (V
•
A/Q
• ) lung regions (see also
Capnography during weaning from mechanical ventilation,
below).
The normal capnogram is the measurement of PCO2 at the
airway opening during the ventilatory cycle (Fig. 1b) [1].
Phase I (inspiratory baseline) reflects inspired gas, which
is normally devoid of carbon dioxide. Phase II (expiratory
upstroke) is the transition between VDana, which does not
participate in gas exchange, and alveolar gas from the res-
piratory bronchioles and alveoli. Phase III is the alveolar
plateau. Traditionally, PCO2 of the last alveolar gas
sampled at the airway opening is called the PETCO
2.
Finally, phase IV is the inspiratory downstroke, the begin-
ning of the next inspiration.
However, the capnogram contains no volume information.
Accordingly, the PAE — CO2 [2,3], which is the volume-aver-
aged alveolar PCO2, is a better index of PACO2 than is
PETCO2, which is just a single measurement of PCO2 at the
end of exhalation [2]. A more informative determination of
pulmonary carbon dioxide elimination is VCO2,br, which is
starting to garner clinical acceptance. VCO2,br is the multi-
plication and integration of airway flow and PCO
2 over an
entire respiratory cycle [4–6]. See the section on Future
directions of carbon dioxide kinetics monitoring, below, for
an interpretation and contrast of the measurements of
VCO2,br and PETCO2.
The disposition of carbon dioxide can also be represented
in a hydraulic model (Fig. 3) [3,7]. The large peripheral
tissue compartment drains through a conduit (Q
•
T) into the
small central pulmonary compartment. The central
compartment can be further divided into pulmonary shunt
(V
•
A/Q
• = 0), normal lung (V
•
A/Q
• near unity), and high V
•
A/Q
•
lung units, including VDalv. The tissues produce carbon
dioxide (V
•
CO2,ti), which empties into the peripheral tissue
compartment. Then, carbon dioxide flows by gravity (Q
•
T)
from the higher level peripheral tissue compartment to the
lower level pulmonary compartment. V
•
A, which equals V
•
E
minus VDana and the effects of high V
•
A/Q
• units, eliminates
carbon dioxide from the lung. In this model, Q
•
T affects the
distribution and total amount of carbon dioxide in the
body. For example, at low Q
•
T, retention of carbon dioxide
occurs in the peripheral tissue compartment, and higher
Pv –CO2 is required to restore carbon dioxide delivery to the
lungs. This hydraulic model can help to understand the
meaning of PETCO2 during successful cardiopulmonary
resuscitation (CPR), and to compare PETCO2 with PaCO2
in the assessment of ventilator parameters. See the
section, Effect of positive end-expiratory pressure on
carbon dioxide kinetics, below, which highlights the utility
of the hydraulic model.
Capnometry: current technologies
Capnometry is the measurement of FCO2 in tidal gas at the
airway opening [1,8]. Capnography is the graphic display
of measured FCO2 versus time. Capnometry most com-
monly utilizes infrared light absorption or mass spectrome-
try [9]. Both methods are reliable and relatively accurate.
Capnometers that are used in clinical practice use two dif-
ferent sampling techniques: sidestream or mainstream
Figure 1
(a) Scheme of carbon dioxide stores and transport. PaCO2, arterial
PCO2; PACO2, alveolar PCO2; PETCO2, end-tidal PCO2; V
•
A, alveolar
ventilation; V
•
CO
2,ti, tissue carbon dioxide production; V
•
D, dead space
ventilation; V
•
E, expired ventilation; V
•
I, inspired ventilation. (b) Normal
capnogram (tidal PCO2 versus time). Phase I, inspiratory baseline;
Phase II, expiratory upstroke; Phase III, alveolar plateau; and Phase IV,
inspiratory downstroke. Adapted from Breen [61].
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Figure 2
Effect of alveolar dead space (VDalv). The right lung compartment
receives no perfusion and contains no carbon dioxide (ignoring
interlung unit ventilation). By mass balance for carbon dioxide, 
VDalv/VTalv = (PaCO2 – PETCO2)/PaCO2. For the sample condition
shown, VDalv/VTalv = (40–20)/40= 50%. PaCO2, arterial PCO2; PACO2,
alveolar PCO2; PETCO2, end-tidal PCO2; Pv –CO2, mixed venous PCO2;
VTalv, alveolar tidal volume. Adapted from Breen [61].
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sampling. A mainstream capnometer has an airway adaptor
cuvette attached in-line and close to the endotracheal tube
(ETT). The cuvette incorporates an infrared light source
and sensor that senses carbon dioxide absorption to
measure PCO2. A sidestream capnometer uses a sampling
line that attaches to a T-piece adapter at the airway
opening, through which the instrument continually aspi-
rates tidal airway gas for analysis of carbon dioxide.
Mainstream capnometry
The main advantage of the mainstream analyzer is its rapid
response, because the measurement chamber is part of
the breathing circuit. The sample cuvette lumen, through
which inspired and expired gases pass, is large in order to
minimize the work of breathing, and pulmonary secretions
generally do not interfere with carbon dioxide analysis.
Compared with sidestream sampling, the airway cuvette is
relatively bulky and can add dead space. However, within
the past few years lighter and smaller airway cuvettes have
been developed to allow its use in neonates [10,11]. The
analyzer is warmed to prevent condensation on the
sample chamber window, and caution must be taken to
prevent burns. The monitoring of PETCO2 in nonintubated
patients is more difficult with mainstream sampling.
Sidestream capnometry
The sidestream PCO2 analyzer adds only a light T-adapter
to the breathing circuit, and can be easily adapted to nonin-
tubation forms of airway control. Because the sampling
tubing is small-bore, it can be blocked by secretions.
During sidestream capnography, the dynamic response,
the steepness of the expiratory upstroke and inspiratory
downslope, tends to be blunted because of the dispersive
mixing of gases through the sampling line [4,12,13], where
gas of high PCO
2 mixes with gas of low PCO2. In addition, a
washout time is required for the incoming sampled gas to
flush out the volume of the measuring chamber. The overall
effect is an averaging of the capnogram, resulting in a low-
ering of the alveolar plateau and an elevation of the inspira-
tory baseline. Thus, PETCO2 may be underestimated and
rebreathing can be simulated [12,14]. These problems are
exacerbated by high ventilatory rates and by the use of long
sampling catheters. In addition, the capnogram is delayed
in time by transport delay, the time required to aspirate gas
from the airway opening adapter through the sampling
tubing to the sampling chamber [4,12]. In conditions of low
fresh gas flow (eg closed circle circuit anesthesia), the
amount of gas sampled and removed from the breathing
circuit needs to be considered.
Portable capnometers
Although portable capnometers exist, their use in the field
can be hindered by cost and requirement for calibration
[15]. The portable infrared analyzer will not operate in tem-
peratures that are subzero or greater than 40°C. Another
device that is used for measurement of PCO2 is the chemi-
cal colorimetric airway detector [16], which uses a pH-
sensitive indicator to detect breath-by-breath exhaled
carbon dioxide [15]. The colorimetric airway detector is
interposed between the ETT and the ventilation device.
They have an unopened shelf-life of 15 months. Both adult
and pediatric adaptors exist, but they cannot be used in
infants who weigh less than 1 kg. Because of excessive
flow resistance, they are not suited for patients who are
able to breath spontaneously, and excessive humidity will
render them inoperative in 15–20 min. The devices can be
damaged by mucous, edematous or gastric contents, and
by administration of intratracheal epinephrine. Despite
these drawbacks, colorimetric sensors have been found to
be useful in guiding prehospital CPR both in intubated
patients and those with a laryngeal mask airway [15,17].
Traditional use of capnography: airway
patency and assessment of ventilation
Because the lung is the only body compartment in which
carbon dioxide normally and continuously accumulates, the
presence of cyclic exhaled carbon dioxide can be used to
confirm airway patency and pulmonary ventilation. Although
initially adopted for anesthesia monitoring in the operating
room, the use of capnography to confirm airway patency
and lung ventilation has expanded over the past 8 years to
include critical care, emergency medicine, field resuscita-
tion, and conscious sedation settings [1,8,15,18–22].
However, there are pitfalls in the use of capnography to
confirm endotracheal intubation. Potential problems with
Figure 3
Hydraulic model of carbon dioxide kinetics in the body. Large
peripheral tissue carbon dioxide compartment (left) drains through
cardiac output (Q
•
T) into the smaller central pulmonary carbon dioxide
compartment (right). FCO2, fractional carbon dioxide; FRC, functional
residual capacity; PaCO2 arterial PCO2; Pv –CO2, mixed venous PCO2;
V
•
A/Q
• , ventilation : perfusion ratio; V
•
CO2,ti, tissue carbon dioxide
production; VDana, anatomical dead space; V
•
E, exhaled ventilation (see
text). Adapted from Breen and Mazumdar [3].
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PvCO2technology are described above. In addition, several sce-
narios have been described that impact on the ability of
capnography to assess the airway and ventilation.
First, during circulatory arrest, pulmonary ventilation will
result in low and decreasing values of exhaled carbon
dioxide because Q
•
T and carbon dioxide transport from the
tissues to the lung are decreased or absent in the pres-
ence of continuing V
•
A [23–25]. In the clinical setting,
however, Vukmir et al [19] demonstrated that infrared
capnography was 100% specific and sensitive in the
detection of endotracheal versus esophageal intubation in
100 critical care cases of airway management, 17 of
which were cardiac arrests.
Second, positive-pressure ventilation by face mask can
force pharyngeal gas, containing exhaled carbon dioxide
from the previous breath, into the esophagus and stomach
[1]. Likewise, ingestion of carbonated beverages can also
generate carbon dioxide in the stomach [26]. Subsequent
esophageal intubation and gastric ventilation can result in
initial cyclic ‘exhaled’ carbon dioxide. However,
esophageal intubation usually causes an initial ‘PETCO2’
that is less than 10 mmHg and that decreases with each
‘exhaled breath’ as inspiration dilutes carbon dioxide in the
stomach [27]. In the case of suspected esophageal intu-
bation, consider interpreting the value of exhaled carbon
dioxide after the sixth breath [15].
Third, in a case report in a neonate weighing under 700 g
[28], although the ETT tube was correctly positioned in
the trachea, displacement of the ETT against the lateral
wall of the trachea resulted in a flat capnogram and an
erroneous diagnosis of esophageal intubation.
Fourth, pathology that causes absence of ventilation,
including severe bronchospasm, patient apnea, or
plugged ETT will result in absence of expired carbon
dioxide and a falsely negative diagnosis that the ETT is not
in the trachea.
Finally, it is prudent to remember that a normal capnogram
confirms ventilation of the lungs through a patent airway,
but not necessarily a secure airway. In a case report [29],
a normal capnogram resulted during ventilation through an
ETT positioned at the glottic opening, but not securely
placed in the trachea.
Despite these potential drawbacks, capnography remains
the most reliable monitor of airway patency in a variety of
experimental and clinical settings. Mickelson et al [30]
demonstrated that exhaled carbon dioxide was the most
reliable indicator of esophageal intubation in canine
model. Likewise, Knapp et al [31] studied current methods
of verifying tracheal tube placement in the critical care
setting, and found that capnography was superior to
auscultation or other devices such as the lighted stylet.
Capnography can also recognize esophageal intubation in
neonates [32]. In the field, compared with other devices
carbon dioxide monitoring best detects esophageal intu-
bation by limiting the number of false negatives and false
positives [15].
In addition to confirmation of ETT placement in the
trachea, capnography may aid in cases of difficult intuba-
tion. During awake, blind, nasotracheal intubation, the end
of a sidestream capnometer sampling probe can be
placed through and positioned at the distal end of the ETT
[33]. Then, increasing values of cyclic exhaled PCO2 can
help guide the ETT to the glottic opening. During a difficult
intubation, effective ventilation can be maintained through
a tube at the tip of the pharynx (guided by the expiratory
carbon dioxide waveform), until other adjuncts to intuba-
tion are available [34].
Sidestream capnography adapts well to the nonintubated,
sedated patient. Croswell et al [35] compared monitoring
by capnography, pulse oximetry and clinical observation in
sedated, pediatric, dental patients. Capnography provided a
minimum 15 s warning of potential arterial desaturation, and
was the most sensitive method for detecting airway com-
promise, especially during deeper levels of sedation. With
oral/nasal capnometry in pediatric patients after active
seizures, Abrams et al [36] demonstrated that PETCO2 is a
useful predictor of hypercapnia and is more sensitive than
pulse oximetry in predicting impending respiratory failure.
Other studies [8,37] have supported the assertion that
capnography provides the earliest warning of airway
obstruction and respiratory compromise.
Finally, capnography is a useful monitor during transport of
intubated, critically ill patients [38,39]. Beside the obvious
advantage of early warning against ETT dislodgment
and/or compromise of ventilation, monitoring of PETCO2
(as an estimate of PaCO2) may aid the management of
patients in whom hypercapnia is detrimental, such as
patients with head injury with raised intracranial pressure
and pediatric patients with pulmonary hypertension [38].
Capnography during weaning from mechanical
ventilation
Capnography has been considered a potentially useful
noninvasive monitor to assess the weaning of patients
from mechanical ventilation in critical care settings [40].
However, studies have shown variable results in the ability
of PETCO2 to predict PaCO2. Whether the use of PETCO2
can limit the need for invasive arterial blood gas monitor-
ing has yet to be established.
In a 1985–1991 literature review of the efficacy of nonin-
vasive blood gas monitoring in the adult critical care unit
[41], the Technology Subcommittee of the Working
Critical Care    Vol 4 No 4 Anderson and BreenGroup on Critical Care (Ontario Ministry of Health) con-
cluded that changes in PETCO2 need to be interpreted with
extreme caution. Healey et al [42] compared the correla-
tion of PETCO2 with PaCO2 before and after withdrawal of
assist control mechanical ventilation. PETCO2 paralleled
changes in PaCO2 (r = 0.82). Saura et al [43], in a
prospective study to evaluate the relationship between
PaCO2 and PETCO2 before and during weaning with contin-
uous positive airway pressure ventilation, also found that
PETCO2 could detect clinically relevant hypercapnic
episodes. However, there was a high incidence of false
positives that led to arterial blood gas sampling. Withing-
ton et al [44] found that, after a gradient between PaCO2
and PETCO2 was established, PETCO2 was a useful para-
meter in the weaning of postcardiac surgery patients.
The assessment of PETCO2 may be misleading if not con-
sidered in the context of changing hemodynamics and
ventilatory pattern. Although there can be significant cor-
relation of PETCO2 with PaCO2, clinically acceptable sensi-
tivity and specificity may only occur in the absence of
significant changes in Q
•
T or V
•
A/Q
• relationships. In evalu-
ating the use of capnography as a noninvasive monitor of
PaCO2 in critical care patients, Morley et al [45] observed
that PETCO2 was useful as a predictor only in patients
without significant parenchymal lung disease. Prause [46]
found that PETCO2 was useful for the adjustment of venti-
latory parameters in prehospital emergency care patients
only if they had no major cardiopulmonary damage. As
depicted in Fig. 2, the gradient between PETCO2 and
PaCO2 depends on VDalv (ie the amount of lung regions
with high or infinite V
•
A/Q
• ratios) [2,25]. Lung regions
with high V
•
A/Q
• ratios can result from high alveolar pres-
sures (eg large VT, positive end-expiratory pressure
[PEEP]), low pulmonary perfusion pressures (eg low Q
•
T,
upright position), and obstruction of pulmonary blood
flow (eg thrombus, gas, or fat embolism). Thus, in the crit-
ically ill patient, VDalv often changes and affects the ability
of PETCO2 to predict PaCO2 and be a substitute for arterial
blood gas sampling.
Capnography during nonsteady-state conditions
Capnography during cardiopulmonary resuscitation
An important and relatively successful application of
capnography in the nonsteady-state clinical setting has
been during CPR [1,3,25]. During cardiac arrest, the
abrupt decrease in Q
•
T results in reduction in carbon
dioxide transport from the tissues to lung and, hence,
decreased carbon dioxide elimination from the lung. With
subsequent successful CPR, the increase in Q
•
T restores
pulmonary blood flow and carbon dioxide transport, and
increases pulmonary elimination of carbon dioxide. Con-
trast this nonsteady-state effect of Q
•
T upon carbon dioxide
kinetics with the steady-state equation (Eqn 1) for carbon
dioxide kinetics. Q
•
T does not even appear in Equation 1,
although it is the conduit for V
•
CO2,ti.
The measurement of exhaled carbon dioxide is the best
signal of return of spontaneous circulation during CPR
[23,24]. Capnography is also a useful noninvasive index of
the adequacy of pulmonary perfusion during closed-chest
cardiac compression [47,48]. In fact, capnography may be
used to compare the efficacy of different modes of chest
compression [49].
Moreover, the quantitative measurement of PETCO
2 may
have predictive value during CPR. This was recognized as
early as 1939, when Eisenmenger wrote “If during a resus-
citation attempt the analysis of the expired air, performed
about twice per hour, still shows plenty of carbon dioxide,
then continuation of artificial respiration (and circulation)
would be indicated” [50]. Asplin and White [20] measured
the 1-min value, the 2-min value, and the maximum value of
PETCO2 during CPR in 27 patients. The initial PETCO2
values were prognostic for return of spontaneous circula-
tion. Finally, the predictive value of PETCO2 has been
studied in hospital settings. Domsky et al [51], in a retro-
spective chart review of 100 critically ill surgery patients,
found that a persistent PETCO2 of 28 mmHg or less was
associated with a mortality rate of 55%, versus a mortality
of 17% in patients with higher PETCO2. Mortality rate was
also increased in patients with a persistent PaCO2–PETCO2
difference of 8 mmHg or more. Quantitative capnography
during resuscitation will continue to evolve.
Future directions of carbon dioxide kinetics monitoring
The following three sections examine how clinically rele-
vant perturbations (application of PEEP, onset of pul-
monary embolism, and recovery from pulmonary
embolism) affect nonsteady-state carbon dioxide kinetics.
The use of relatively new measurements (VCO2,br, PAE — CO2)
will help define pathophysiology and will improve, we
believe, clinical diagnosis and treatment.
Effect of positive end-expiratory pressure on carbon dioxide
kinetics
The addition of PEEP to mechanical ventilation should
acutely decrease VCO2,br, due to decreased V
•
A (increased
VDphy) and decreased carbon dioxide transfer to the lung
(decreased Q
•
T and venous return) [1,3]. Then, gradual
recovery of VCO2,br would occur if peripheral tissue carbon
dioxide retention caused sufficient increase in Pv –CO2
(especially at sustained low Q
•
T) to restore carbon dioxide
delivery to the lung (Fig. 3).
The initial effects during the first 25 breaths after adding
11 cmH2O PEEP to mechanical ventilation of anesthetized
dogs are shown in Fig. 4 [3]. The summation of the
decreases in VT, compared with the baseline value, permit-
ted calculation of increased functional residual capacity
(FRC) at 1152 ml. PETCO2 paralleled the decrease in VT,
but recovered to baseline by breath 10. VCO2,br decreased
from baseline (7.6 ml) to zero in the first couple of exhala-
http://ccforum.com/content/4/4/207tions. However, VCO2,br had only increased to 4.9 ml by
breath 25. From a baseline value (3.3 l/min), Q
•
T (ascend-
ing aorta flow probe) decreased to 1.6 l/min by breath 10,
which was sustained through breath 25. During measure-
ments extended to 25 min, depressed Q
•
T was sustained
and VCO2,br was still 17% less than baseline. PEEP
caused an immediate and sustained increase in VDphy from
312 to 366 ml, resulting entirely from the increase in VDana.
PETCO2 continued to increase to the 25 min value
(43 ± 6 mmHg), which was significantly greater than base-
line. There were parallel changes in PaCO2 and Pv –CO2.
A study of the hydraulic model of carbon dioxide kinetics
(Fig. 3) will help to summarize [1,3]. PEEP immediately
decreased VCO2,br by the following mechanisms:
decreased V
•
A, itself caused by the increase in VDana and
by appearance of new high V
•
A/Q
• lung units; and
decreased PACO2 caused by decreased Q
•
T and, hence,
reduced carbon dioxide transfer from the tissues to the
lung. Dilution of PACO2 with fresh gas as FRC increased at
onset of PEEP was offset by decreased VCO2,br (including
the effect of initial decreased exhaled VT). Sustained
decrease in VCO2,br at 25 min occurred because V
•
A
remained depressed from continued increased VDphy.
Then, VCO2,br could only recover to the baseline value if
PACO2 significantly increased. However, at persistently
decreased Q
•
T, the increase in tissue carbon dioxide reten-
tion and Pv –CO2 were not enough to restore carbon dioxide
delivery to the lung and sufficiently increase PACO2.
PETCO2, because it does not measure exhaled volume,
failed to correctly estimate VCO2,br. Steady state was not
reached by 25 min of PEEP. A parallel study of the effects
of PEEP on carbon dioxide kinetics in anesthetized
patients [52] demonstrated less marked changes, presum-
ably because the intact thorax in patients blunted the
increase in FRC and VDana and the intact pleural pressure
gradient limited the generation of high V
•
A/Q
• lung units.
Other studies, in patients with acute respiratory failure
[53,54], have demonstrated the limitations of interpreting
changes in the PaCO2–PETCO2 gradient during PEEP.
Effect of pulmonary embolism on carbon dioxide kinetics
Pulmonary embolism should cause a different V
•
A/Q
• abnor-
mality, the generation of pure VDalv. The embolus will block
perfusion to lung units, converting them into VDalv [1,25].
The increase in VDalv will increase VDphy and result in
decreased V
•
A and, hence, VCO2,br. Eventually, tissue
carbon dioxide retention and increased Pv –CO2 would
restore carbon dioxide delivery from the tissue to the lung
and VCO2,br. Presumably, persistent VDalv during pulmonary
embolus would preclude the accuracy of PETCO2 as an
estimate of either PaCO2 or VCO2,br.
To examine these hypotheses, an animal model similar to
the PEEP study (above) was invoked, except that the per-
turbation was abrupt tightening of a snare around the right
pulmonary artery (RPA) [1,55]. Compared with baseline
(9.3 ml), average VCO2,br decreased to 7.0 ml by 1 min
after RPA occlusion (Fig. 5). At the same time, PETCO2
decreased from 29 to 22 mmHg. During the following 70
min of RPA occlusion, VCO2,br steadily increased to
approach the baseline value. In contrast, at 70 min of RPA
occlusion, PETCO2 was still 13% less than baseline. PaCO2
and Pv –CO2 progressively converged on their maxima (high
values) by 70 min. Q
•
T, despite an initial tendency to
decrease, did not change significantly.
In summary, large experimental pulmonary embolus imme-
diately decreased VCO2,br by 25%, almost entirely due to
an increase in VDalv (Fig. 2). VCO2,br increased and recov-
ered to baseline as carbon dioxide was retained in the
body, signaled by the progressive increases in PaCO2 and
Pv –CO2. PETCO2 remained significantly less than baseline
due to persistent increased VDalv, and detected neither the
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Figure 4
Initial breath-by-breath effects of adding 11 cmH2O PEEP in
mechanically ventilated anesthetized dogs on carbon dioxide volume
exhaled per breath (VCO2,br), end-tidal PCO2 (PETCO2), exhaled tidal
volume (VT), and cardiac output (Q
•
T, aorta flow probe). PaCO2, arterial
PCO2; Pv –CO2, mixed venous PCO2. Adapted from Breen and Mazumdar
[3].
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Because Q
•
T did not significantly decrease, Pv –CO2 could
increase sufficiently to restore carbon dioxide delivery to
the lung.
Resolution of pulmonary embolism
Patients with large pulmonary embolism can suffer progres-
sive hypercapnia and may require emergent embolectomy,
either by the transvenous or open thoracic approach. Con-
ceivably, the functional recovery of carbon dioxide exchange
could signal reperfusion of the affected pulmonary circula-
tion and help guide the course of surgical therapy.
Accordingly, using the experimental model of pulmonary
embolism (above), the RPA was occluded for 70 min to
approach steady state. Then, the RPA snare was abruptly
released and measurements were repeated during 70 min
of RPA reperfusion [1,56]. At onset of RPA reperfusion,
VCO2,br abruptly increased from 9 to 12 ml. By 70 min of
RPA reperfusion, VCO2,br returned to the baseline value.
Immediately after RPA reperfusion, PETCO2 increased from
25 to 33 mmHg because VDalv/VTalv decreased by 41%.
At 70 min, PETCO2 was still greater than baseline. PaCO2
and Pv –CO2 steadily decreased during 70 min of RPA
reperfusion, modeling the release of carbon dioxide reten-
tion in the central pulmonary and peripheral tissue carbon
dioxide compartments. Q
•
T did not change significantly.
In summary, VCO2,br detects and follows the resolution of
carbon dioxide retention in lung and tissues during
reperfusion after experimental pulmonary embolus. In
contrast, PETCO2 did not detect the secondary slow
decrease in VCO2,br back to baseline because PETCO2
measures neither exhaled volume nor the shape of the
PCO2 waveform.
Accordingly, during onset and resolution of pulmonary
embolism, this analysis of nonsteady-state carbon dioxide
kinetics may aid the clinical assessment of pulmonary
embolism [57].
Although beyond the scope of the present review, volu-
metric capnography (ie the carbon dioxide expirogram, the
plot of exhaled PCO2 versus exhaled volume) can also yield
information about lung volume [58], dead space [59], and
pulmonary blood flow (carbon dioxide rebreathing tech-
nique) [60].
Conclusion
In our opinion, better understanding of pathophysiology of
carbon dioxide kinetics during steady and nonsteady state
should improve clinical care during intensive care treat-
ment. Capnography and the measurement of PETCO2 will
gradually be augmented by relatively new measurement
methodology (including VCO2,br and PAE — CO2). Future direc-
tions include the study of oxygen kinetics [1].
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